Sofia Agelaki

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Apostolaki Stella; Perraki Maria; Kallergi Galatea; Kafousi Maria; Papadopoulos Savvas; Kotsakis Athanasios; Pallis Athanasios; Xenidis Nikolaos; Kalmanti Lyda; Kalbakis Kostas; Agelaki Sofia; Kalykaki Antonia; Stournaras Christos; Stathopoulos Efstathios; Georgoulias Vassilis; Mavroudis Dimitris
Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.
Bozionelou Vasiliki; Kalbakis Kostas; Vamvakas Lambros; Agelaki Sofia; Androulakis Nikolaos; Kalykaki Antonia; Georgoulias Vassilis; Mavroudis Dimitris
A phase I trial of gemcitabine, docetaxel and carboplatin administered every 2 weeks as first line treatment in patients with advanced breast cancer.
Pallis Athanasios G; Agelidou Athina; Agelaki Sofia; Varthalitis Ioannis; Pavlakou Georgia; Gerogianni Aleka; Papakotoulas Pavlos; Rapti Ageliki; Chandrinos Vassilis; Christophyllakis Charalampos; Georgoulias Vassilis
A multicenter randomized phase II study of the irinotecan/gemcitabine doublet versus irinotecan monotherapy in previously treated patients with extensive stage small-cell lung cancer.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Sofia Agelaki (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Apostolaki Stella; Perraki Maria; Kallergi Galatea; Kafousi Maria; Papadopoulos Savvas; Kotsakis Athanasios; Pallis Athanasios; Xenidis Nikolaos; Kalmanti Lyda; Kalbakis Kostas; Agelaki Sofia; Kalykaki Antonia; Stournaras Christos; Stathopoulos Efstathios; Georgoulias Vassilis; Mavroudis Dimitris
Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.
Breast cancer research and treatment 2009;117(3):525-34.
2009: Bozionelou Vasiliki; Kalbakis Kostas; Vamvakas Lambros; Agelaki Sofia; Androulakis Nikolaos; Kalykaki Antonia; Georgoulias Vassilis; Mavroudis Dimitris
A phase I trial of gemcitabine, docetaxel and carboplatin administered every 2 weeks as first line treatment in patients with advanced breast cancer.
Cancer chemotherapy and pharmacology 2009;64(4):785-91.
2009: Pallis Athanasios G; Agelidou Athina; Agelaki Sofia; Varthalitis Ioannis; Pavlakou Georgia; Gerogianni Aleka; Papakotoulas Pavlos; Rapti Ageliki; Chandrinos Vassilis; Christophyllakis Charalampos; Georgoulias Vassilis
A multicenter randomized phase II study of the irinotecan/gemcitabine doublet versus irinotecan monotherapy in previously treated patients with extensive stage small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2009;65(2):187-91.
2009: Xenidis Nikolaos; Ignatiadis Michail; Apostolaki Stella; Perraki Maria; Kalbakis Kostas; Agelaki Sofia; Stathopoulos Efstathios N; Chlouverakis Grigorios; Lianidou Evi; Kakolyris Stylianos; Georgoulias Vassilis; Mavroudis Dimitris
Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(13):2177-84.
2008: Kallergi Galatea; Agelaki Sofia; Kalykaki Antonia; Stournaras Christos; Mavroudis Dimitris; Georgoulias Vassilis
Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients.
Breast cancer research : BCR 2008;10(5):R80.
2007: Bozionelou V; Vamvakas L; Pappas P; Agelaki S; Androulakis N; Kalykaki A; Nikolaidou M; Kentepozidis N; Giassas S; Marselos M; Georgoulias V; Mavroudis D
A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and gemcitabine in patients with advanced solid tumours.
British journal of cancer 2007;97(1):43-9.
2007: Apostolaki S; Perraki M; Pallis A; Bozionelou V; Agelaki S; Kanellou P; Kotsakis A; Politaki E; Kalbakis K; Kalykaki A; Vamvakas L; Georgoulias V; Mavroudis D
Circulating HER2 mRNA-positive cells in the peripheral blood of patients with stage I and II breast cancer after the administration of adjuvant chemotherapy: evaluation of their clinical relevance.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(5):851-8.
2007: Souglakos J; Kalykaki A; Vamvakas L; Androulakis N; Kalbakis K; Agelaki S; Vardakis N; Tzardi M; Kotsakis A P; Gioulbasanis J; Tsetis D; Sfakiotaki G; Chatzidaki D; Mavroudis D; Georgoulias V
Phase II trial of capecitabine and oxaliplatin (CAPOX) plus cetuximab in patients with metastatic colorectal cancer who progressed after oxaliplatin-based chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(2):305-10.
2007: Pallis A G; Christofillakis Ch; Tselepatiotis E; Agelaki S; Vamvakas L; Souglakos J; Vardakis N; Kalykaki A; Kotsakis A; Argiraki A; Mavroudis D; Georgoulias V
Sequential administration of docetaxel followed by maintenance gefitinib, as salvage treatment in patients with advanced NSCLC: a multicenter phase II trial.
Lung cancer (Amsterdam, Netherlands) 2007;55(1):101-7.
2007: Kallergi Galatea; Agelaki Sofia; Markomanolaki Harris; Georgoulias Vassilis; Stournaras Christos
Activation of FAK/PI3K/Rac1 signaling controls actin reorganization and inhibits cell motility in human cancer cells.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2007;20(6):977-86.
2007: Emmanouilides Christos; Sfakiotaki Georgia; Androulakis Nikolaos; Kalbakis Kostas; Christophylakis Charalambos; Kalykaki Antonia; Vamvakas Lambros; Kotsakis Athanasios; Agelaki Sofia; Diamandidou Eleni; Touroutoglou Nikolaos; Chatzidakis Adam; Georgoulias Vassilis; Mavroudis Dimitris; Souglakos John
Front-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study.
BMC cancer 2007;7():91.
2007: Souglakos J; Vardakis N; Androulakis N; Kakolyris S; Kourousis C; Mavroudis D; Pallis A; Agelaki S; Kalbakis K; Georgoulias V
Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: a phase II trial.
Digestive diseases (Basel, Switzerland) 2007;25(1):100-5.
2006: Ardavanis Alexandros; Mavroudis Dimitris; Kalbakis Kostas; Malamos Nikolaos; Syrigos Kostas; Vamvakas Lambros; Kotsakis Athanasios; Kentepozidis Nikolaos; Kouroussis Charalambos; Agelaki Sophia; Georgoulias Vassilis;
Pegylated liposomal doxorubicin in combination with vinorelbine as salvage treatment in pretreated patients with advanced breast cancer: a multicentre phase II study.
Cancer chemotherapy and pharmacology 2006;58(6):742-8.
2006: Hatzidaki Dora; Agelaki Sofia; Mavroudis Dimitris; Vlachonikolis Ioannis; Alegakis Athanasios; Georgoulias Vassilis;
A retrospective analysis of second-line chemotherapy or best supportive care in patients with advanced-stage non-small-cell lung cancer.
Clinical lung cancer 2006;8(1):49-55.
2006: Pallis Athanasios G; Agelidou Athina; Papakotoulas Pavlos; Tsaroucha Aimilia; Agelidou Maria; Agelaki Sohia; Androulakis Nikolaos; Vamvakas Lambros; Gerogianni Athina; Kotsakis Athanasios; Kentepozidis Nikolaos; Georgoulias Vassilis
A multicenter phase II study of sequential vinorelbine and cisplatin followed by docetaxel and gemcitabine in patients with advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2006;52(2):165-71.
2006: Karampeazis A; Vamvakas L; Agelaki S; Kentepozidis N; Papadimitraki E; Gioulbasanis I; Vardakis N; Ignatiadis M; Mavroudis D; Georgoulias V
A dose escalation study of biweekly oral vinorelbine and gemcitabine in patients with solid tumors.
Oncology 2006;71(5-6):347-53.
2006: Kalykaki A; Vamvakas L; Agelaki S; Kalbakis K; Vardakis N; Sfakiotaki G; Ignatiadis M; Saridaki Z; Karampeazis A; Mavroudis D; Georgoulias V
A dose escalation study of gemcitabine plus pemetrexed administered biweekly in patients with solid tumors.
Oncology 2006;71(3-4):197-203.
2006: Kotsakis A; Kouroussis Ch; Androulakis N; Agelaki S; Kalbakis K; Vamvakas L; Vardakis N; Kalykaki A; Polyzos A; Georgoulias V; Mavroudis D
A dose-escalation study of pegylated liposomal Doxorubicin and oxaliplatin in patients with advanced solid tumors.
Oncology 2006;71(3-4):190-6.
2005: Agelaki Sofia; Georgoulias Vassilis
Epidermal growth factor receptor inhibitors in the treatment of non-small cell lung cancer.
Expert opinion on emerging drugs 2005;10(4):855-74.
2005: Papadimitrakopoulou Vali; Agelaki Sofia; Tran Hai T; Kies Merrill; Gagel Robert; Zinner Ralph; Kim Edward; Ayers Gregory; Wright John; Khuri Fadlo
Phase I study of the farnesyltransferase inhibitor BMS-214662 given weekly in patients with solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(11):4151-9.
2005: Souglakos J; Vardakis N; Androulakis N; Kakolyris S; Kouroussis Ch; Mavroudis D; Pallis A; Agelaki S; Kalbakis K; Georgoulias V
Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: A phase II trial.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2005;10(1):47-52.
2005: Souglakos J; Pallis A; Kakolyris S; Mavroudis D; Androulakis N; Kouroussis C; Agelaki S; Xenidis N; Milaki G; Georgoulias V
Combination of irinotecan (CPT-11) plus 5-fluorouracil and leucovorin (FOLFIRI regimen) as first line treatment for elderly patients with metastatic colorectal cancer: a phase II trial.
Oncology 2005;69(5):384-90.
2005: Souglakos John; Kakolyris Stylianos; Vardakis Nikolaos; Androulakis Nikolaos; Mavroudis Dimitrios; Vamvakas Lambos; Kouroussis Charalambos; Agelaki Sophia; Saridaki Zacharenia; Georgoulias Vassilis
A dose escalating study of oxaliplatin and high dose weekly leucovorin and 5-Fluorouracil in patients with advanced solid tumors.
Cancer investigation 2005;23(6):505-10.
2004: Kouroussis Charalambos; Kalbakis Konstantinos; Androulakis Nikolaos; Agelaki Sophia; Vamvakas Lambros; Malas Konstantinos; Souglakos John; Vardakis Nikolaos; Georgoulias Vassilis
A dose escalation study of leucovorin (LV) and 48-hour continuous infusion of 5-fluorouracil in combination with cyclophosphamide and vinorelbine in pretreated patients with metastatic breast cancer.
Anticancer research 2004;24(6):4217-21.
2004: Christidou Athanassia; Maraki Sofia; Scoulica Efstathia; Mantadakis Elpis; Agelaki Sofia; Samonis George
Fatal Nocardia farcinica bacteremia in a patient with lung cancer.
Diagnostic microbiology and infectious disease 2004;50(2):135-9.
2004: Kouroussis Charalambos; Mavroudis Dimitris; Kakolyris Stylianos; Voloudaki Argyro; Kalbakis Konstantinos; Souglakos John; Agelaki Sophia; Malas Konstantinos; Bozionelou Vassiliki; Georgoulias Vassilis
High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patients with non-small cell lung cancer: results of a dose-finding study.
Lung cancer (Amsterdam, Netherlands) 2004;44(3):363-8.
2004: Agelaki Sofia; Veslemes Marinos; Syrigos Kostas; Palamidas Filippos; Polyzos Aristidis; Papakotoulas Pavlos; Kentepozidis Nikolaos; Milaki Georgia; Tzanakis Nikolaos; Kouroussis Charalambos; Vamvakas Lambros; Georgoulias Vassilis;
A multicenter phase II study of the combination of gemcitabine and docetaxel in previously treated patients with small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2004;43(3):329-33.
2004: Agelaki Sofia; Syrigos Kostas; Christophylakis Charalambos; Boukovinas John; Varthalitis John; Pavlakou Georgia; Athanasiadis Athanasios; Kouroussis Charalambos; Vardakis Nikolaos; Maltezakis George; Milaki Georgia; Georgoulias Vassilis;
A multicenter phase II study of the combination of irinotecan and gemcitabine in previously treated patients with small-cell lung cancer.
Oncology 2004;66(3):192-6.
2004: Kakolyris S; Souglakos J; Kouroussis C; Androulakis N; Samonis G; Vardakis N; Amarantidis K; Agelaki S; Mavroudis D; Xenidis N; Georgoulias V
Dose escalation study on oxaliplatin and capecitabine (Xeloda) in patients with advanced solid tumors.
Oncology 2004;66(4):253-9.
2003: Stathopoulos G P; Rigatos S K; Dimopoulos M A; Giannakakis T; Foutzilas G; Kouroussis C; Janninis D; Aravantinos G; Androulakis N; Agelaki S; Stathopoulos J G; Georgoulias V;
Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic Cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(3):388-94.
2003: Mavroudis D; Pappas P; Kouroussis C; Kakolyris S; Agelaki S; Kalbakis K; Androulakis N; Souglakos J; Vardakis N; Nikolaidou M; Samonis G; Marselos M; Georgoulias V
A dose-escalation and pharmacokinetic study of gemcitabine and oxaliplatin in patients with advanced solid tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(2):304-12.
2003: Kouroussis Charalambos; Agelaki Sophia; Mavroudis Dimitris; Kakolyris Stylianos; Androulakis Nick; Kalbakis Kostas; Souglakos John; Mallas Kostas; Bozionelou Vassiliki; Pallis Athanasios; Adamtziki Helen; Georgoulias Vassilis
A dose escalation study of docetaxel and oxaliplatin combination in patients with metastatic breast and non-small cell lung cancer.
Anticancer research 2003;23(1B):785-91.
2003: Mavroudis D; Pavlakou G; Blazoyiannakis G; Veslemes M; Apostolopoulou F; Kouroussis Ch; Kakolyris S; Agelaki S; Androulakis N; Vardakis N; Magkanas E; Samonis G; Georgoulias V
Sequential administration of cisplatin-etoposide followed by topotecan in patients with extensive stage small cell lung cancer. A multicenter phase II study.
Lung cancer (Amsterdam, Netherlands) 2003;39(1):71-6.
2003: Agelaki S; Karyda E; Kouroussis Ch; Ardavanis A; Kalbakis K; Malas K; Malamos N; Alexopoulos A; Tselepatiotis E; Georgoulias V
Gemcitabine plus irinotecan in breast cancer patients pretreated with taxanes and anthracyclines: a multicenter phase II study.
Oncology 2003;64(4):477-8.
2003: Mavroudis D; Alexopoulos A; Malamos N; Ardavanis A; Kandylis C; Stavrinidis E; Kouroussis Ch; Agelaki S; Androulakis N; Bozionelou V; Georgoulias V
Salvage treatment of metastatic breast cancer with docetaxel and carboplatin. A multicenter phase II trial.
Oncology 2003;64(3):207-12.
2002: Kouroussis Charalambos; Souglakos John; Mavroudis Dimitris; Papadouris Savvakis; Kakolyris Stylianos; Agelaki Sophia; Kalbakis Kostas; Panopoulos Christos; Vardakis Nikos; Sarra Evanthia; Georgoulias Vassilis
Oxaliplatin with high-dose leucovorin and infusional 5-fluorouracil in irinotecan-pretreated patients with advanced colorectal cancer (ACC).
American journal of clinical oncology 2002;25(6):627-31.
2002: Giannakakis Theodore; Kakolyris Stelios; Theodoropoulos Elias; Kouroussis Charalambos; Michailakis Emmanuel; Papadouris Savvakis; Tsitoura Miranda; Kalbakis Kostas; Souglakos John; Agelaki Sohia; Vardakis Nikos; Georgoulias Vassilis
A multicenter phase II study of docetaxel and carboplatin combination as front-line treatment in advanced non-small cell lung cancer.
Anticancer research 2002;22(6B):3743-8.
2002: Agelaki Sofia; Tsatsanis Christos; Gravanis Achille; Margioris Andrew N
Corticotropin-releasing hormone augments proinflammatory cytokine production from macrophages in vitro and in lipopolysaccharide-induced endotoxin shock in mice.
Infection and immunity 2002;70(11):6068-74.
2002: Androulakis N; Kouroussis C; Mavroudis D; Kakolyris S; Souglakos J; Agelaki S; Kalbakis K; Malas K; Pallis A; Samonis G; Georgoulias V
Phase I study of weekly paclitaxel and liposomal doxorubicin in patients with advanced solid tumours.
European journal of cancer (Oxford, England : 1990) 2002;38(15):1992-7.
2002: Souglakos John; Kotsakis Athanaslos; Kouroussis Charalambos; Kakolyris Stylianos; Mavroudis Dimitrios; Kalbakis Konstadinos; Agelaki Sofia; Vlachonikolis John; Georgoulias Vassilis; Samonis George
Nonneutropenic febrile episodes associated with docetaxel-based chemotherapy in patients with solid tumors.
Cancer 2002;95(6):1326-33.
2002: Souglakos J; Mavroudis D; Kakolyris S; Kourousis Ch; Vardakis N; Androulakis N; Agelaki S; Kalbakis K; Tsetis D; Athanasiadis N; Samonis G; Georgoulias V
Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: a multicenter phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(11):2651-7.
2002: Mavroudis D; Kouroussis Ch; Kakolyris S; Agelaki S; Kalbakis K; Androulakis N; Souglakos J; Samonis G; Georgoulias V
Phase I study of paclitaxel (taxol) and pegylated liposomal doxorubicin (caelyx) administered every 2 weeks in patients with advanced solid tumors.
Oncology 2002;62(3):216-22.
2002: Kosmas C; Agelaki S; Giannakakis Th; Mavroudis D; Kouroussis Ch; Kalbakis K; Papadouris S; Souglakos J; Malamos N; Georgoulias V
Phase I study of vinorelbine and carboplatin combination in patients with taxane and anthracycline pretreated advanced breast cancer.
Oncology 2002;62(2):103-9.
2001: Agelaki S; Bania H; Kouroussis C; Blazoyiannakis G; Souglakos J; Tsiafaki X; Kalbakis K; Rapti A; Androulakis N; Georgoulias V; Papadakis E
Second-line treatment with vinorelbine and carboplatin in patients with advanced non-small cell lung cancer. A multicenter phase II study.
Lung cancer (Amsterdam, Netherlands) 2001;34 Suppl 4():S77-80.
2001: Kakolyris S; Kouroussis C; Souglakos J; Agelaki S; Kalbakis K; Vardakis N; Vamvakas L; Georgoulias V
Cisplatin and irinotecan (CPT-11) as second-line treatment in patients with advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2001;34 Suppl 4():S71-6.
2001: Agelaki S; Kakolyris S; Palamidas P; Kouroussis C; Mavroudis D; Kalbakis K; Georgoulias V; Raptis A
A dose escalation study of topotecan in combination with epirubicin in pretreated patients with small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2001;34(1):133-9.
2001: Kalbakis K; Kouroussis C; Kakolyris S; Mavroudis D; Souglakos J; Agelaki S; Vamvakas L; Christodoulakis M; Stylianou K; Georgoulias V
Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanes.
British journal of cancer 2001;85(6):798-802.
2001: Kouroussis C; Kakolyris S; Mavroudis D; Androulakis N; Kalbakis K; Agelaki S; Sarra E; Souglakos J; Christodoulakis M; Samonis G; Georgoulias V
A dose-finding study of the weekly administration of paclitaxel in patients with advanced solid tumors.
American journal of clinical oncology 2001;24(4):404-7.
2001: Alexopoulos A; Kouroussis C; Malamos N; Kakolyris S; Kalbakis K; Kosmas C; Mavroudis D; Agelaki S; Vlachonicolis J; Sarra E; Rigatos G; Georgoulias V
Docetaxel in combination with mitoxantrone and granulocyte colony-stimulating factor as front-line chemotherapy in metastatic breast cancer: a multicenter phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(6):793-8.
2001: Kakolyris S; Papadakis E; Tsiafaki X; Kalofonos C; Rapti A; Toubis M; Bania E; Kouroussis C; Chainis K; Androulakis N; Agelaki S; Sarra E; Vardakis N; Georgoulias V;
Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study.
Lung cancer (Amsterdam, Netherlands) 2001;32(2):179-87.
2001: Kakolyris S; Mavroudis D; Tsavaris N; Souglakos J; Tsiafaki P; Kalbakis K; Agelaki S; Androulakis N; Georgoulias V
Paclitaxel in combination with carboplatin as salvage treatment in refractory small-cell lung cancer (SCLC): a multicenter phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(2):193-7.
2001: Stathopoulos G P; Mavroudis D; Tsavaris N; Kouroussis C; Aravantinos G; Agelaki S; Kakolyris S; Rigatos S K; Karabekios S; Georgoulias V
Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor: a phase II study of the Greek Cooperative Group for Pancreatic Cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(1):101-3.
2001: Kakolyris S; Kouroussis C; Souglakos J; Mavroudis D; Agelaki S; Kalbakis K; Androulakis N; Vardakis N; Vamvakas L; Georgoulias V
A phase I clinical trial of topotecan given every 2 weeks in patients with refractory solid tumors.
Oncology 2001;61(4):265-70.
2001: Agelaki S; Bania H; Kouroussis C; Blazoyiannakis G; Souglakos J; Tsiafaki X; Harpidou A; Kalbakis K; Rapti A; Androulakis N; Sarra E; Georgoulias V; Papadakis E
Vinorelbine-based regimens as salvage treatment in patients with advanced non-small cell lung cancer: two parallel multicenter phase II trials.
Oncology 2001;60(3):235-41.
2000: Kakolyris S; Souglakos J; Agelaki S; Kourousis C H; Mavroudis D; Sarra E; Malliotakis P; Georgoulias V
A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapy.
Lung cancer (Amsterdam, Netherlands) 2000;30(3):193-8.
2000: Mavroudis D; Alexopoulos A; Ziras N; Malamos N; Kouroussis C; Kakolyris S; Agelaki S; Kalbakis K; Tsavaris N; Potamianou A; Rigatos G; Georgoulias V
Front-line treatment of advanced breast cancer with docetaxel and epirubicin: a multicenter phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(10):1249-54.
2000: Mavroudis D; Kourousis C; Androulakis N; Kalbakis K; Agelaki S; Kakolyris S; Souglakos J; Sarra E; Vardakis N; Hatzidaki D; Sarmonis G; Georgoulias V
Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF): a phase II trial.
American journal of clinical oncology 2000;23(4):341-4.
2000: Giannakakis T; Ziras N; Kakolyris S; Mavroudis D; Androulakis N; Agelaki S; Parashos M; Sarra E; Dimou T; Hatzidaki D; Vlachonikolis J; Georgoulias V
Docetaxel in combination with carboplatin for the treatment of advanced non-small cell lung carcinoma: a multicentre phase I study.
European journal of cancer (Oxford, England : 1990) 2000;36(6):742-7.
2000: Mavroudis D; Kourousis C; Kakolyris S; Agelaki S; Kalbakis K; Androulakis N; Souglakos J; Vardakis N; Samonis G; Georgoulias V
Phase I study of the gemcitabine/oxaliplatin combination in patients with advanced solid tumors: a preliminary report.
Seminars in oncology 2000;27(1 Suppl 2):25-30.
2000: Kouroussis C; Agelaki S; Mavroudis D; Souglakos J; Kakolyris S; Kalbakis K; Vardakis N; Reppa D; Hatzidaki D; Samonis G; Georgoulias V
A dose escalation study of weekly docetaxel in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2000;46(6):488-92.
1999: Kakolyris S; Kourousis C; Koukourakis M; Androulakis N; Vamvakas L; Agelaki S; Hatzidaki D; Samonis G; Tsiftsis D; Georgoulias V
First-line treatment of metastatic breast cancer with mitoxantrone, vinorelbine, and carboplatin.
American journal of clinical oncology 1999;22(6):568-72.
1999: Kakolyris S; Samonis G; Koukourakis M; Vlachonicolis J; Kalbakis K; Agelaki S; Chalkiadakis G; Sanidas E; Tsiftsis D; Georgoulias V
First-line treatment with mitoxantrone, methotrexate, vincristine, and carboplatine (MIMOC) plus cyclical hormonotherapy with tamoxifen and megestrol acetate in advanced breast cancer.
American journal of clinical oncology 1999;22(3):273-7.
1999: Kouroussis C; Xydakis E; Potamianou A; Giannakakis T; Kakolyris S; Agelaki S; Sara E; Malamos N; Alexopoulos A; Mavroudis D; Samonis G; Papadouris S; Georgoulias V; Panagos G
Front-line treatment of metastatic breast cancer with docetaxel and epirubicin: a multicenter dose-escalation study. The Greek Breast Cancer Cooperative Group (GBCCG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(5):547-52.
1999: Mavroudis D; Malamos N; Alexopoulos A; Kourousis C; Agelaki S; Sarra E; Potamianou A; Kosmas C; Rigatos G; Giannakakis T; Kalbakis K; Apostolaki F; Vlachonicolis J; Kakolyris S; Samonis G; Georgoulias V
Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: a multicenter phase II trial. Greek Breast Cancer Cooperative Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(2):211-5.
1998: Kakolyris S; Samonis G; Koukourakis M; Vlachonicolis I; Chalkiadakis G; Kalbakis K; Souglakos I; Agelaki S; Toloudis P; Georgoulias V
Treatment of non-small-cell lung cancer with prolonged oral etoposide.
American journal of clinical oncology 1998;21(5):505-8.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Sofia Agelaki

Research Profile (preview)

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Sofia Agelaki (preview)

All Publications